A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms
Authors
Keywords
-
Journal
Expert Review of Hematology
Volume 4, Issue 6, Pages 637-655
Publisher
Informa UK Limited
Online
2011-11-11
DOI
10.1586/ehm.11.63
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]
- (2012) Hans Carl Hasselbalch CURRENT DRUG TARGETS
- Interferon Treatment in Patients with Hypereosinophilia
- (2012) Ole Weis Bjerrum CURRENT DRUG TARGETS
- Interferon alpha for Treatment of Chronic Myeloid Leukemia
- (2012) Bengt Simonsson et al. CURRENT DRUG TARGETS
- Interferon-Alpha in the Treatment of Multiple Myeloma
- (2012) Khoo CURRENT DRUG TARGETS
- Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
- (2011) J. Thiele et al. BLOOD
- Recombinant interferon- may retard progression of early primary myelofibrosis: a preliminary report
- (2011) R. T. Silver et al. BLOOD
- The renaissance of interferon therapy for the treatment of myeloid malignancies
- (2011) J.-J. Kiladjian et al. BLOOD
- Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-
- (2011) C. H. Riley et al. BLOOD
- Peginterferon Alfa-2a Is Superior to Peginterferon Alfa-2b in the Treatment of Naïve Patients with Hepatitis C Virus Infection: Meta-Analysis of Randomized Controlled Trials
- (2011) Ashwani K. Singal et al. DIGESTIVE DISEASES AND SCIENCES
- Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis
- (2011) Vibe Skov et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Hydroxycarbamide: a user’s guide for chronic myeloproliferative disorders
- (2011) Jerry L Spivak et al. Expert Review of Anticancer Therapy
- Interferon Alfa in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms
- (2011) Hans Carl Hasselbalch et al. JOURNAL OF CLINICAL ONCOLOGY
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Polycythemia Vera With Hydroxyurea and Pipobroman: Final Results of a Randomized Trial Initiated in 1980
- (2011) Jean-Jacques Kiladjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Interferon-α in acute myeloid leukemia: an old drug revisited
- (2011) S Anguille et al. LEUKEMIA
- Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha
- (2010) Philip T. Murphy et al. ANNALS OF HEMATOLOGY
- Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity
- (2010) Paola Rizza et al. AUTOIMMUNITY
- Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia
- (2010) L. Parmeggiani et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera
- (2010) P. Foa et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Recombinant α2a interferon and polycythemia vera: Clinical results and biological evaluation by means of Fourier-transform infrared microspectroscopy
- (2010) F. Papineschi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera
- (2010) N. Heis et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Remission may continue after termination of rIFNα -2b treatment for essential thrombocythemia
- (2010) H. Kasparu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- How does interferon exert its cell growth inhibitory effect?
- (2010) Dan Grandér et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Clonal analysis of erythroid progenitors suggests that pegylated interferon α-2a treatment targets JAK2 V617F clones without affecting TET2 mutant cells
- (2010) J-J Kiladjian et al. LEUKEMIA
- Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
- (2010) Claude Preudhomme et al. NEW ENGLAND JOURNAL OF MEDICINE
- PEG-IFN-α-2a therapy in patients with myelofibrosis
- (2009) Jean-Christophe Ianotto et al. BRITISH JOURNAL OF HAEMATOLOGY
- Induction of complete remission of acute myeloid leukaemia by pegylated interferon-α-2a in a patient with transformed primary myelofibrosis
- (2009) Zwi N. Berneman et al. BRITISH JOURNAL OF HAEMATOLOGY
- Redefining the role of interferon in the treatment of malignant diseases
- (2009) Sergio Bracarda et al. EUROPEAN JOURNAL OF CANCER
- Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission
- (2009) Thomas Stauffer Larsen et al. Hematology
- Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
- (2009) Alfonso Quintás-Cardama et al. JOURNAL OF CLINICAL ONCOLOGY
- Recombinant interferon alpha (rIFNα-2b) may retard progression of early primary myelofibrosis
- (2009) R T Silver et al. LEUKEMIA
- Interferon: Does it still have a role in the 21st century?
- (2009) Peter McLaughlin et al. LEUKEMIA & LYMPHOMA
- IFNα activates dormant haematopoietic stem cells in vivo
- (2009) Marieke A. G. Essers et al. NATURE
- Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon–dependent exhaustion
- (2009) Taku Sato et al. NATURE MEDICINE
- Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera
- (2008) T. S. Larsen et al. ANNALS OF HEMATOLOGY
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy
- (2008) Martin Griesshammer et al. BLOOD REVIEWS
- The management and outcome of four pregnancies in women with idiopathic myelofibrosis
- (2008) Sameer Tulpule et al. BRITISH JOURNAL OF HAEMATOLOGY
- Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosis
- (2008) Veronika Buxhofer-Ausch et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms
- (2008) J-J Kiladjian et al. LEUKEMIA
- Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group
- (2008) Eva Kimby et al. LEUKEMIA & LYMPHOMA
- Myelofibrosis with myeloid metaplasia: The advanced phase of an untreated disseminated hematological cancer
- (2008) Hans Carl Hasselbalch LEUKEMIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started